Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Colorectal Neoplasms 255Rectal Neoplasms 155Colonic Neoplasms 128Stomach Neoplasms 100Pancreatic Neoplasms 94Breast Neoplasms 77Esophageal Neoplasms 76Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 56Head and Neck Neoplasms 56Neoplasms 43Adenocarcinoma Of Esophagus 37Esophageal Squamous Cell Carcinoma 27Adenocarcinoma 25Unspecified Adult Solid Tumor, Protocol Specific 15Carcinoma, Hepatocellular 15Parkinson Disease 4, Autosomal Dominant Lewy Body 13Anus Neoplasms 12Keratosis, Actinic 11Gastrointestinal Neoplasms 11Biliary Tract Neoplasms 11Gallbladder Neoplasms 10Carcinoma, Squamous Cell 10Urinary Bladder Neoplasms 9Nasopharyngeal Carcinoma 9Liver Neoplasms 9Cholangiocarcinoma 9Carcinoma 9Bile Duct Neoplasms 9Recurrence 8

Interventions

adavosertib 3Paclitaxel 3olaparib 2durvalumab 2Fluorouracil 2Carboplatin 2danvatirsen 1capivasertib 1Pantoprazole 1Leucovorin 1Irinotecan 1Injections 1Gemcitabine 1Doxorubicin 1Cisplatin 1AZD0156 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Advanced Solid Tumours × Fluorouracil × Clear all
NCT03421353 2024-08-21

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

AstraZeneca

Phase 1 Completed
76 enrolled
Other solid neoplasm

Advanced Solid Tumours

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed
84 enrolled
Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon âš¡